Entrada Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold TRDA, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

20
Funds holding
$47725021
Total value held
Buying
17 added/new · 3 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $19013332 2583333 +224540 +9.52%
2 Merck & Co., Inc. $12804692 1739768 +1739768 NEW BUY
3 State Street Corp $4391543 596677 +62879 +11.78%
4 Jpmorgan Chase & Co $3827683 496457 +481610 +3243.82%
5 Northern Trust Corp $2281173 309942 +74950 +31.89%
6 Morgan Stanley $1410544 191650 +15524 +8.81%
7 Goldman Sachs Group Inc $1305247 177343 -35437 -16.65%
8 Bank Of New York Mellon Corp $581955 79070 +2643 +3.46%
9 Ameriprise Financial Inc $518107 70395 +70395 NEW BUY
10 Bank Of America Corp /De/ $426343 57927 +18715 +47.73%
11 Invesco Ltd. $326372 44344 +44344 NEW BUY
12 Ubs Group Ag $305911 41564 +41564 NEW BUY
13 Barclays Plc $210495 28600 -76 -0.27%
14 Wells Fargo & Company/Mn $183279 24902 +13891 +126.16%
15 Citigroup Inc $108854 14790 +10666 +258.63%
16 Federated Hermes, Inc. $14484 1968 +1968 NEW BUY
17 Pnc Financial Services Group, Inc. $8354 1135 -6 -0.53%
18 Royal Bank Of Canada $6000 882 +857 +3428.00%
19 Zions Bancorporation, National Association /Ut/ $640 87 +87 NEW BUY
20 Amalgamated Financial Corp. $13 1350 +1350 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.